TLPPF - Telix Pharmaceuticals Limited reports Q2 results
- Telix Pharmaceuticals Limited press release ( OTCPK:TLPPF ): Q2 Revenue of $22.5M (+1078.0% Y/Y).
- As of 30 June 2022, the company held cash reserves of $122.6M.
- The company has 5.5 quarters runway based on net cash used in operations in the June 2022 quarter.
For further details see:
Telix Pharmaceuticals Limited reports Q2 results